The yap/taz signaling pathway in the tumor microenvironment and carcinogenesis: Current knowledge and therapeutic promises


Abstract:

The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators, members of the Hippo signaling pathway, which play a critical role in cell growth regulation, embryonic development, regeneration, proliferation, and cancer origin and progression. The mechanism involves the nuclear binding of the un-phosphorylated YAP/TAZ complex to release the transcriptional enhanced associate domain (TEAD) from its repressors. The active ternary complex is responsible for the aforementioned biological effects. Overexpression of YAP/TAZ has been reported in cancer stem cells and tumor resistance. The resistance involves chemotherapy, targeted therapy, and immunotherapy. This review provides an overview of YAP/TAZ pathways’ role in carcinogenesis and tumor microenvironment. Potential therapeutic alternatives are also discussed.

Año de publicación:

2022

Keywords:

  • Hippo signaling pathway
  • immunotherapy
  • Carcinogenesis
  • YAP/TAZ
  • Drug resistance
  • cell proliferation
  • Neoplastic stem cells
  • Chemoresistance
  • tumor microenvironment
  • TEAD

Fuente:

scopusscopus

Tipo de documento:

Review

Estado:

Acceso abierto

Áreas de conocimiento:

  • Cáncer
  • Cáncer

Áreas temáticas:

  • Medicina y salud
  • Enfermedades